$115.00
The 10mg clinical protocol format of OVA’s thymic immune peptide — for women running full 12-week Thymosin Alpha-1 protocols for immune reconstitution, chronic fatigue, or autoimmune support.
3-5 business days
SSL encrypted
Thymosin Alpha-1 at 10mg provides a complete 6-week protocol at the standard clinical dose (1.6mg 2x/week = 3.2mg/week), or a 12-week protocol at maintenance dosing. At this format, it’s appropriate for women committed to a full immune restoration cycle — the immune reconstitution effects of Tα1 are cumulative, with NK cell activity and T-cell counts measurably improved by week 6–8 of consistent use.
For women with chronic immune dysregulation, autoimmune conditions, or post-viral fatigue syndromes, the 10mg format means an uninterrupted protocol without mid-course supply gaps. The immune-modulating effects build progressively: week 2–3 for innate immune changes (NK activity), week 4–6 for T-cell subset normalization, and week 8–12 for adaptive immune recalibration in chronic conditions.
Female-calibrated dosing: 1.6mg subcutaneously 2x/week for 6–12 weeks. The 10mg vial supports approximately 6 weeks at this dose. For chronic conditions, a second vial and extended protocol (12–16 weeks) may be indicated under clinical supervision.
Storage: Store lyophilized powder below -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
| Dosage | 10mg |
|---|---|
| Format | Injectable Vial |
| Cycle Length | 6–12 weeks |
| Storage | Freeze until use. Refrigerate after reconstitution. Use within 30 days. |
Reviews
There are no reviews yet.